OBJECTIVES: Accurate risk assessments are particularly important for elderly patients being considered for lobectomy. Considering the positive effects of the thoracoscopic approach on postoperative outcomes, we sought to review the reliability of the established risk factors for elderly patients undergoing thoracoscopic lobectomy.
INTRODUCTION
The number of elderly patients with early-stage lung cancer is expected to increase rapidly because of the current demographic trends [1] . Increased age is associated with impaired respiratory performance and a greater burden of comorbidities [2, 3] . These age-related changes in turn cause a higher risk of postoperative mortality and morbidity following major lung resection [4, 5] . Moreover, elderly patients have limited physiological reserve to cope with the increased stress associated with postoperative complications [6] . Thus, an accurate preoperative risk assessment and careful patient selection are particularly important for this special patient population.
Thoracoscopic lobectomy has been widely adopted in the past decade and is currently the recommended surgical approach for the treatment of early-stage lung cancer. Cumulative evidence has demonstrated that relative to thoracotomy, thoracoscopic lobectomy results in reduced postoperative mortality and morbidity, particularly in high-risk patients, e.g. those with impaired pulmonary function or older age [5, 7, 8] . In fact, a propensity score-matched study found a 6-fold decrease in the odds of morbidity in elderly patients after thoracoscopic lobectomy compared with an open approach [5] . Accordingly, there is growing interest in the application of this minimally invasive procedure in elderly patients. This development has also raised the important question of the validity of previously published risk assessment models, which are based on clinical data primarily obtained from open lung resections [9] . Given the positive effects of the thoracoscopic approach on postoperative outcomes, it is reasonable to speculate that the magnitude and the impact of established morbidity predictors may be altered in elderly patients undergoing thoracoscopic lobectomy.
In this study, we reviewed our institutional database regarding thoracoscopic major lung resection and explored the relationships between established predictors and postoperative complications following thoracoscopic lobectomy in elderly patients with early-stage lung cancer.
PATIENTS AND METHODS
A retrospective study was performed using our institutional database, which includes retrospective data on thoracoscopic major lung resections from 2009 to 2014 and prospective data thereafter. All adult patients undergoing thoracoscopic lobectomy for early-stage non-small-cell lung cancer were included in this study. Patients older than 70 years were considered elderly, because the age of 70 is usually considered the lower boundary of senescence [10] . In fact, organ dysfunction and comorbid conditions increase sharply after this age [3] . We compared the clinical outcomes of elderly patients with those of younger patients. This study was approved by the local institutional review board, and specific patient consent was waived.
All patients received computed tomography and positron emission tomography scans as well as brain magnetic resonance imaging to screen for regional and distal metastases. Patients with suspected mediastinal nodal metastases underwent endobronchial ultrasound-guided fine-needle aspiration or transcervical mediastinoscopy. Intensive assessment of clinical history, physiological evaluation and laboratory tests were obtained in all patients prior to surgery. Performance status of patients was considered marginal or poor for an Eastern Cooperative Oncology Group (ECOG) scale > _2. The predicted postoperative value of forced expiratory volume in 1 s expressed as the percent predicted (ppoFEV 1 %) and the diffusing capacity of the lung expressed as the percent predicted (ppoDLCO%) were calculated using the functional segment technique; in this technique, preoperative FEV 1 % or DLCO% was multiplied by the fraction of the functional lung segments expected to remain after lobectomy [9] . All patients with preoperative lung function testing that demonstrated impaired pulmonary function (ppoFEV 1 % or ppoDLCO% <40) were submitted to a stair-climbing test or cardiopulmonary exercise testing (cycle ergometry) as additional risk stratification measures prior to lobectomy. When the performance of the patients on the stair-climbing test was not satisfactory, cycle ergometry was indicated to determine their eligibility. A maximum oxygen consumption greater than 10 ml/kg/min or 35% of predicted was considered sufficient for lobectomy.
Comorbidity was assessed using the Charlson comorbidity index (CCI). In this study, we adopted an updated version of the CCI that encompassed 23 medical conditions, which are summarized in Table 1 [11] . Compared with the original version, the updated version includes 4 more comorbid conditions including hypertension, depression, use of warfarin and skin ulcers/cellulitis and was found to better predict health outcomes in previous analyses of data from the national population health surveys [12] . Because the lung cancer patients involved in this study underwent thoracoscopic lobectomies with a curative intent, lung cancer was not scored as a malignancy, in accordance with previous reports. Additionally, modifications were made to score coronary artery disease and myocardial infarction together with a value of 1. Moderate or severe comorbidity was indicated when the CCI score was > _3.
All cases were preoperatively reviewed by our multidisciplinary lung oncology team, which includes oncologists, respiratory physicians, radiologists, pathologists, nuclear medicine physicians and thoracic surgeons. As a measure of overall health status, the American Society of Anesthesiologists physical status (ASA-PS) was determined by the responsible anaesthesiologists for all patients prior to surgery according to the modern version [13] . Lung cancer staging was performed according to the American Joint Committee on Cancer seventh edition manual [14] . Pathological stage was reported based on the final histopathological findings after lobectomy and radical mediastinal lymph node dissection. In our institution, thoracoscopic lobectomy is performed using a 3-port approach, including a 3-cm anterolateral access incision in the fourth intercostal space without rib spreading and with visualization through the monitor only. Lobar vessels and the bronchus are individually ligated, and the hilar and the mediastinal lymph nodes are dissected.
Mortality was defined as death during hospitalization for thoracoscopic lobectomy or within 30 days of the operation. Postoperative complications were defined according to the Society of Thoracic Surgeons and the European Society of Thoracic Surgeons (STS/ESTS) joint standardization of variable definitions and terminology [15] . Pulmonary complications included pneumonia, atelectasis requiring bronchoscopy, adult respiratory distress syndrome, initial ventilator support >48 h and unplanned reintubation or tracheotomy. Cardiovascular complications were defined as acute myocardial infarction, pulmonary embolism and atrial or ventricular arrhythmia requiring intervention. All other adverse events including postoperative bleeding, wound infection, recurrent laryngeal nerve injury, bronchopleural fistula and other relevant events were defined as 'other major complications'. Although postoperative bleeding and recurrent laryngeal nerve injury result mostly from technical complications, we considered them to be other major complications because they are commonly associated with other serious adverse events. Overall morbidity was defined as the occurrence of any major complication including mortality.
Statistical analysis
Categorical variables were expressed as percentages and were evaluated with the Fisher's exact test. Continuous data were presented as the median and interquartile range and were compared using the Wilcoxon rank-sum test. Logistic regression analyses were performed to explore the relationships between established risk factors and postoperative complications in elderly patients. The variables included were gender (male), ppoFEV 1 %, ppoDLCO%, CCI score (3 vs <3), ECOG performance status (> _2 vs <2) and ASA-PS scale (3 vs <3). While ppoFEV 1 % and ppoDLCO% were modelled as continuous variables, the remaining variables were modelled as binary categorical variables. To evaluate the causal effect of gender on postoperative pulmonary complications in elderly patients, the nearest neighbour propensity score matching with replacement was used to establish male and female elderly patients with balanced demographics and clinical characteristics. To estimate the size of the causal effect, generalized linear mixed model with random effects was fitted. Because matching might introduce a dependency structure, each male patient together with all of his matched female counterparts were considered as an individual group and associated with a random intercept in the logistic regression model. To account for the fact that a male patient could be matched to more than 1 female patient, the reciprocal number of this male patient's drawings was used as a weight, whenever this male patient occurred in the matched data set. To evaluate the robustness of the above approach, propensity score adjustment using inverse probability of treatment weighting was performed. In this method, a weight was calculated for each subject that was equal to the inverse of the estimated probability of receiving the treatment (gender) that was actually received, conditionally on the observed covariates. These weights were then incorporated into a logistic regression model to estimate the effect of gender on the outcome variable [16] . Statistical significance was determined by a P-value <0.05. Propensity score matching and analysis using generalized linear mixed model, as well as inverse probability of treatment weighting, were conducted using R Project for Statistical Computing, version 3.3.3, along with R package 'MatchIt' version 2.4-22, 'lme4' version 1.1-13 and 'ipw' 1.0-11 [17] [18] [19] [20] . The other statistical analyses were performed using SPSS, version 16.0 for Windows (SPSS, Chicago, IL, USA).
RESULTS
From 2009 through March 2016, 441 patients underwent thoracoscopic lobectomy for clinical early-stage non-small-cell lung cancer at our institution. There were 191 women and 250 men, with a median age of 68 (61-74) years. In 12 (2.7%) patients, the thoracoscopic approach had to be converted to open thoracotomy to complete the lobectomy. Impaired pulmonary function (ppoFEV 1 % or ppoDLCO% <40) was observed in 113 patients in the entire cohort. Of these patients, 49 underwent cycle ergometry with maximum oxygen consumption measurements ranging from 10.9 to 27.0 ml/kg/min (43.0-162.0%). Pathological analysis indicated Stage I in 341 (77.3%) patients, Stage II in 67 (15.2%) patients and Stage III in 33 (7.5%) patients.
Of the included patients, 176 were elderly and 265 were younger. Patient demographics and clinical characteristics are provided in Table 2 . Compared with younger patients, elderly patients were more likely to be men. Moderate or severe comorbidity (CCI > _3) and severe systemic disease (ASA-PS Grade 3) were more likely in elderly patients. No patients had an ASA-PS scale >3. The incidences of each comorbid condition are summarized in Table 1 . The most common comorbid conditions were hypertension and chronic pulmonary disease, followed by cardiac disease and diabetes without end-organ damage. Two patients had a history of metastatic solid tumour: 1 patient with breast cancer and solitary cerebellar metastasis and the other with prostate cancer and a bony metastasis. Both patients received treatment with a curative intent and were disease-free from prior tumours. Compared with younger patients, elderly patients were more likely to have hypertension, diabetes and cardiovascular disease.
Four postoperative deaths (0.9%) occurred in the entire patient cohort. Three patients died from postoperative pneumonia, while 1 patient developed bronchopleural fistula, followed by multiple organ failure and died on postoperative Day 12. Postoperative pulmonary and cardiovascular complications and overall morbidity occurred in 36 (8.2%), 24 (5.4%) and 105 (23.8%) patients, respectively. The rates of postoperative complications including mortality in both groups are depicted in Table 3 . Elderly patients had higher postoperative complication rates than younger patients. However, these differences did not reach statistical significance. There was a trend towards a higher pulmonary complication rate in elderly patients (P = 0.052). In the univariable logistic regression analyses restricted to elderly patients, postoperative complications were not related to ppoFEV 1 %, ppoDLCO%, moderate or severe comorbidity (CCI > _3) or worse performance status (ECOG > _2, Table 4 ). In contrast, more than a 6-fold increase in the odds of pulmonary complications was observed in elderly male patients compared with their female counterparts. In addition, the ASA-PS was the only strong predictor of pulmonary and cardiopulmonary complication rates and overall morbidity. Compared with patients with ASA-PS Grade <3, the odds of pulmonary and cardiopulmonary complications increased nearly 6-fold and 3-fold, respectively, in those with an ASA-PS Grade 3. Because of the limited postoperative adverse events and concern about misleading results, multivariable logistic regression analysis was not performed.
To further explore the causal effect of gender on postoperative pulmonary complications in elderly patients, propensity score matching was used to identify male and female elderly patients with balanced demographics and clinical characteristics. Of the 176 elderly patients, there were 111 men and 65 women. Compared with elderly women, elderly men had significantly lower ppoDLCO% values and were significantly more likely to have a history of smoking and moderate or severe comorbidity (Table 5) . Additionally, there was a moderate trend towards a lower ppoFEV 1 % and a higher incidence of overweight in elderly male patients. Accordingly, propensity scores were assessed using a multivariable logistic regression model, which included overweight (body mass index > _25 kg/m 2 vs <25 kg/m 2 ), history of smoking, ppoFEV 1 %, ppoDLCO%, CCI (> _3 vs <3) and pathological stage (advanced vs early). Because of very different distribution of propensity scores in 2 groups, the nearest neighbour propensity score matching with replacement was performed. The matching established 2 well-balanced groups consisting of 29 male and 65 female elderly patients (Table 6 ). After the matching process, the pulmonary complication rate was significantly higher in elderly male patients than in their female counterparts (20.7% vs 3.1%, P = 0.010). Our analysis of matched data using generalized linear mixed model indicated that male gender was associated with more than an 8-fold increase in the odds of pulmonary complications [odds ratio (OR) 8.591, 95% confidence interval 1.284-57.456; P = 0.027]. To evaluate the robustness of the above-mentioned results, we additionally performed propensity score adjustment using inverse probability of treatment weighting, which revealed more than a 3-fold increase in the odds of pulmonary complications in elderly male patients compared with elderly female patients (OR 3.290, 95% confidence interval 1.531-7.738, P = 0.004).
COMMENTS
The proportion of elderly patients with lung cancer increases as the population ages. Compared with younger patients, elderly patients are more likely to have higher comorbidity burden and worse physical status; these trends were reflected in our analyses of preoperative clinical characteristics. Despite the exposure to these risk factors, thoracoscopic lobectomy resulted in low mortality and reasonable morbidity in our elderly patient cohort. Our data support those of previously reported smaller series, which indicated that thoracoscopic lobectomy is safe and justifiable for elderly patients with early-stage lung cancer [21, 22] . Although an increasing amount of evidence has demonstrated the positive effect of thoracoscopic lobectomy on the postoperative outcomes of elderly patients, the authors believe that the favourable outcomes in our elderly patient cohort were also attributable to the thorough risk assessment and careful patient selection performed before surgery. Indeed, both ppoFEV 1 % and ppoDLCO% in the elderly patients were comparable to those of their younger counterparts. In addition, the majority of our elderly patients presented with a good preoperative performance status (ECOG <2). Careful patient selection is one of the most important responsibilities of a surgeon and is particularly important when the patients are old and present with relevant comorbidities [23] . However, from a statistical perspective, our data were affected by substantial selection bias, which may explain why ppoFEV 1 %, ppoDLCO% and ECOG performance status were not related to postoperative complications.
Interestingly, we found that the ASA-PS was a strong predictor of postoperative adverse outcomes following thoracoscopic lobectomy in elderly patients. Compared with elderly patients with an ASA-PS Grade <3, those with an ASA-PS Grade 3 had approximately 6-fold and 3-fold greater odds of pulmonary and cardiopulmonary complications, respectively. The ASA-PS is a classification system that assesses a patient's overall health status and degree of sickness. This scale has been widely used by anaesthesiologists to estimate the operative and anaesthesiological risk. Despite the inherent subjectivity of this scoring system, the predictive ability of the ASA-PS for postoperative complications has been extensively studied and validated in a number of clinical studies. A recent large study involving over 2.3 million patients demonstrated that the ASA-PS has strong, independent associations with postoperative mortality and morbidity [24] . To date, limited data exist regarding the ASA-PS as a predictor of morbidity after major lung resection. Only a few prospective studies have identified the ASA-PS as an independent risk factor for postoperative atrial fibrillation and pulmonary complications following open lung resection [25, 26] . Notably, the ASA-PS scale has rarely been considered in the risk assessment process prior to major lung resection thus far. Similar to many other centres, in our institution, the ASA-PS was assigned by the responsible anaesthesiologist 1 day before the scheduled surgery. This information was usually not available when the treatment decision was made in our multidisciplinary lung oncology team meeting. Moreover, most lung cancer patients were counselled on the treatment options and risks prior to the anaesthesiologist's determination of the ASA-PS scale. Based on our findings, assignment of the ASA-PS scale is recommended to be integrated into the preoperative risk assessment for elderly patients who are being considered for thoracoscopic lobectomy. Due to the possible inter-rater inconsistency, especially in assigning Grades 2 (mild systemic disease) and 3 (severe systemic disease), elderly patients with ASA-PS Grade > _2 should consult senior anaesthesiologists as early as possible. We believe that incorporating the ASA-PS will enable more accurate preoperative risk assessments and will facilitate decision-making for this frail patient population.
As a normal part of ageing, elderly patients experience a series of respiratory changes in terms of central regulation, chest wall dynamics, parenchymal elasticity and gas exchange [2] . This decline in respiratory performance, especially the reduced efficiency in mucociliary transport and the weakening of respiratory muscles, predisposes elderly patients to postoperative pulmonary complications. Notably, the physiological stress caused by postoperative complications is generally poorly tolerated by elderly patients [6] .
Because of its minimally invasive nature, thoracoscopic lobectomy is associated with less pain and better preservation of lung function in the initial postoperative period. These advantages then enable improved deep breathing and early expectoration and ambulation in the postoperative period, which are crucial for elderly patients [27] . Accordingly, elderly patients seem to be among the greatest beneficiaries of thoracoscopic lobectomy [28] . Nevertheless, in this study, we found that there was a trend towards a higher pulmonary complication rate in elderly patients when compared with their younger counterparts. With a large enough sample size, the difference in pulmonary complication rates between elderly and younger patients may become significant. More importantly, our analysis of propensity-matched data using generalized linear mixed model revealed more than an 8-fold increase in the odds of pulmonary complications for elderly male patients compared with their female counterparts. Interestingly, the alternative analysis using inverse probability of treatment weighting showed a lower OR for pulmonary complication (3.290). However, it is fairly difficult to determine where the discrepancy in the results of the 2 different approaches for causal effect analysis originated from. While propensity score matching with replacement yielded samples with well-balanced baseline characteristics and hence reduced the bias, this advantage was at the cost of a higher variance because of the smaller sample size. The inverse probability of treatment weighting using propensity score, on the other hand, used all data sets and weighted each subject based on propensity score to control for imbalance. This advantage was reflected in the narrower confidence interval for OR in our analysis. However, this approach might have exaggerated the importance of the patients with very low propensity score [29] . Nevertheless, both the analysis of propensity-matched data using generalized linear mixed model and the estimation using inverse probability of treatment weighting indicated a significant effect of male gender on postoperative pulmonary complication in elderly patients undergoing thoracoscopic lobectomy. Our findings again highlight the importance of early postoperative pulmonary care and close monitoring of elderly patients undergoing major lung resection, particularly elderly men.
Limitations
This study has certain limitations. As mentioned above, the thorough risk assessment and careful patient selection prior to surgery may have caused substantial selection bias. The inherent bias of retrospective data was also of concern. The clinical data on thoracoscopic lobectomies were prospectively evaluated only in and after 2015. Therefore, it is possible that some postoperative adverse events were undisclosed in patients undergoing thoracoscopic lobectomy from 2009 through 2014. Additionally, our results were based on data from a single institution, which may not fully reflect other clinical scenarios. Thus, the general applicability of the findings to other institutions is debatable. Similar studies in other institutions or multicentre studies are warranted to confirm and generalize our findings. Despite the imperfect data, our results may help improve preoperative risk assessments and optimize perioperative management of elderly patients with early-stage lung cancer.
CONCLUSION
In conclusion, our results suggest that thoracoscopic lobectomy is safe for appropriately selected elderly patients with early-stage lung cancer. The ASA-PS is a strong predictor of morbidity in elderly patients being considered for thoracoscopic lobectomy. Early involvement of anaesthesiologists in the preoperative risk assessment is recommended to obtain more accurate risk stratifications in this frail patient population. Close monitoring and early postoperative pulmonary care are particularly important for elderly male patients who are more prone to postoperative pulmonary complications than their female counterparts.
